Large-Scale Manufacturing Automation

CDMO Services

At Sinopep, we value media interest in our business, services, and capabilities. You're welcome to explore the resources on this page or contact our media relations team for specific inquiries. We’ll make sure you’re connected with the appropriate business leader or subject matter expert.

CPHI Milan 2026 Exhibition

Exhibition at CPHI Milan 2026

CPHI Milan Has Wrapped Up — Thank You from the Sinopep Team. CPHI Milan has come to a close, and the Sinopep-Allsino team would like to thank everyone who visited us at Booth 4H7 at Fiera Milano.

read more
Formulation Video

Sinopep’s New Formulation Facility

Since its founding in 2004, Sinopep has developed a robust and scalable formulation platform focused on delivering high-quality pharmaceutical products and CDMO solutions. Our recently expanded formulation facility provides even greater production capacity and an expanded range of services for our clients.

read more
Oligonucleotide API Manufacturing

Sinopep Oligonucleotide GMP Manufacturing

Our new GMP oligonucleotide facility represents a major expansion in our ability to manufacture oligonucleotide API and NCE therapeutics, including antisense oligonucleotides (ASOs) and siRNA, at thousands of kilograms annually. Purpose-built to meet the growing global demand for advanced RNA-based medicines, this facility sets a new benchmark for large-scale oligo production.

read more
DCAT 2026 Sinopep Team Photo

2026 DCAT Week with Sinopep

Reflecting on an energizing few days at DCAT 2026 in New York, with great conversations across peptides, oligonucleotides, and small molecules and genuine appreciation for everyone who connected with the Sinopep team.

read more
SInopep exhibition at CPHI India

Exhibition at CPHI India 2025

Show more10:11 AMClaude responded: Reflecting on a productive and energizing week at CPHI India 2025 in Delhi, with strong engagement across peptide and oligonucleotide development, manufacturin…Reflecting on a productive and energizing week at CPHI India 2025 in Delhi, with strong engagement across peptide and oligonucleotide development, manufacturing, and generics partnerships.

read more
Sinopep Headquarters

Sinopep Company Overview Video

Sinopep leads the global market in large-scale production of key GLP-1 receptor agonists—ranking #1 in export volume. With one of the world’s largest and most flexible manufacturing capacities, we support production from milligrams to over 200 kilograms per batch.

read more